Abstract
3LBA Everolimus Added to Exemestane Reduced Bone Markers and Disease Progression in Bone in Postmenopausal Women with Advanced Breast Cancer: Updated Results From the BOLERO-2 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have